Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,977 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials.
Guo J, Wei M, Zhang W, Jiang Y, Li A, Wang C, Yin D, Sun A, Gong Y. Guo J, et al. Among authors: yin d. Front Pharmacol. 2025 Mar 27;16:1517272. doi: 10.3389/fphar.2025.1517272. eCollection 2025. Front Pharmacol. 2025. PMID: 40213686 Free PMC article.
Paradoxical skin lesions induced by IL-17 inhibitors in SAPHO syndrome.
Li Y, Meng F, Jiang H, Peng Q, Fu J, Yin D, Hou X, Li C. Li Y, et al. Among authors: yin d. J Dermatolog Treat. 2024 Dec;35(1):2295239. doi: 10.1080/09546634.2023.2295239. Epub 2023 Dec 28. J Dermatolog Treat. 2024. PMID: 38153122 Free article. No abstract available.
3,977 results